DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 01 · Volume 48 · Januar 2015 DOI: 10.1055/s-004-28360

Erratum

e1
Gahr, M.; Zeiss, R.; Lang, D.; Connemann, B. J.; Hiemke, C.; Freudenmann, R. W.; Schönfeldt-Lecuona, C.: Risk of Bleeding Related to Selective and Non-selective Serotonergic Antidepressants: A Case/Non-case Approach Using Data from Two Pharmacovigilance Databases

Review

1
La Torre, A.; Giupponi, G.; Duffy, D.; Conca, A.; Catanzariti, D.: Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs

Original Paper

7
Soyka, M.; Fischer, W.: No Evidence for Development of Tolerance after Repeated Use of Propofol for Electroconvulsive Therapy
11
Mustafa, F. A.; Burke, J. G.; Abukmeil, S. S.; Scanlon, J. J.; Cox, M.: “Schizophrenia past Clozapine”: Reasons for Clozapine Discontinuation, Mortality, and Alternative Antipsychotic Prescribing
15
Schjerning, O.; Lykkegaard, S.; Damkier, P.; Nielsen, J.: Possible Drug-drug Interaction between Pregabalin and Clozapine in Patients with Schizophrenia: Clinical Perspectives
19
Gahr, M.; Zeiss, R.; Lang, D.; Connemann, B. J.; Hiemke, C.; Freudenmann, R. W.; Schönfeldt-Lecuona, C.: Risk of Bleeding Related to Selective and Non-selective Serotonergic Antidepressants: A Case/Non-case Approach Using Data from Two Pharmacovigilance Databases
25
Lai, C.-L.; Chan, H.-Y.; Pan, Y.-J.; Chen, C.-H.: The Effectiveness of a Computer Reminder System for Laboratory Monitoring of Metabolic Syndrome in Schizophrenic Outpatients Using Second-generation Antipsychotics
30
Kishi, T.; Iwata, N.: Efficacy and Tolerability of Histamine-2 Receptor Antagonist Adjunction of Antipsychotic Treatment in Schizophrenia: A Meta-analysis of Randomized Placebo-controlled Trials
Supporting Information

Letter

37
Gronau, W.; Paslakis, G.; Lederbogen, F.; Weber-Hamann, B.; Gilles, M.; Schilling, C.; Deuschle, M.: Increased Platelet Count after Treatment with Venlafaxine or Mirtazapine in Depressed Patients